CNBCOctober 26, 2026 at 1:23 PM NYYesterday
Lilly and Gilead stand out ahead of healthcare earnings, says Citi's Geoff Meacham

Geoff Meacham, Citi, joins 'Closing Bell Overtime' to look ahead to biopharma earnings on the docket.
Read the Full Story at the Source
The summary here comes from the news provider; the rest of the article lives on the publisher's site: CNBC